Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma

Published:2021-12-11 Issue:1 Volume:17 Page:61-68
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Mollica Veronica,Santoni Matteo,Matrana Marc R.,Basso Umberto,De Giorgi Ugo,Rizzo Alessandro,Maruzzo Marco,Marchetti Andrea,Rosellini Matteo,Bleve Sara,Maslov Diana,Tawagi Karine,Philon Ernest,Blake Zoe,Massari Francesco^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11523-021-00861-y.pdf

Reference38 articles.

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33. https://doi.org/10.3322/caac.21654.

2. Santoni M, Piva F, Porta C, et al. Artificial neural networks as a way to predict future kidney cancer incidence in the United States. Clin Genitourin Cancer. 2021;19:e84–91. https://doi.org/10.1016/j.clgc.2020.10.008.

3. Rini BI, Plimack ER, Stus V, et al. KEYNOTE-426 Investigators. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2019;380:1116–27. https://doi.org/10.1056/NEJMoa1816714.

4. Motzer RJ, Tannir NM, McDermott DF, et al. CheckMate 214 Investigators. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. N Engl J Med. 2018;378:1277–90. https://doi.org/10.1056/NEJMoa1712126.

5. Motzer RJ, Penkov K, Haanen J, et al. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2019;380:1103–15. https://doi.org/10.1056/NEJMoa1816047.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The gut microbiome and dietary metabolites in the treatment of renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2024-08

2. Precision medicine in oncology: role and prospects of mass spectrometry;Bulletin of Siberian Medicine;2024-07-11

3. Effects of Proton Pump Inhibitors on Cardiovascular Events and Inflammatory Factors in Patients With Upper Gastrointestinal Bleeding Undergoing Dual Antiplatelet Therapy;Cureus;2024-05-08

4. Efficacy and safety of proton pump inhibitors on cardiovascular events and inflammatory factors in patients with upper gastrointestinal bleeding undergoing dual antiplatelet therapy;Inflammopharmacology;2024-04-20

5. Emerging trends and thematic evolution of immunotherapy for glioma based on the top 100 cited articles;Frontiers in Oncology;2024-01-12